Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

CompletedOBSERVATIONAL
Enrollment

5,115

Participants

Timeline

Start Date

June 22, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Coronary Artery Disease, Hypercholesterolemia, Hypertension
Interventions
OTHER

No intervention

Because this is a non-interventional study, there is no intervention here.

Trial Locations (54)

100028

China Meitan General Hospital, Beijing

100029

CHINA-JAPAN Friendship Hospital, Beijing

Beijing Anzhen Hospital, Beijing

100038

Fu Xing Hospital Affiliated to Capital Medical University, Beijing

100044

Peking University People's Hospital, Beijing

100048

NAVY General Hospital, Beijing

100053

Guang'anmen hospital, Beijing

Xuanwu Hospital Capital Medical University, Beijing

100089

Hospital attached to aeromedicine institute of P.L.A (466 Hospital), Beijing

102400

The First Hospital of Fangshan District , Beijing, Beijing

102600

People's Hospital of Beijing Daxing District, Beijing

110015

The General Hospital of Shenyang Military, Shenyang

150030

Heilongjiang Provincial Hospital, Harbin

200082

Shanghai University of Traditional Chinese Medicine affiliated Yueyang Hospital of traditional Chine, Shanghai

200433

Shanghai Yangpu District Central Hospital, Shanghai

201111

Shanghai Minhang District Central Hospital, Shanghai

210001

Nanjing Red Cross Hospital, Nanjing

210024

Cardiology Provincial Hospital of Jiangsu Province, Nanjing

211100

Jiangning People's Hospital, Nanjing

211102

Nanjing colleague hospital, Nanjing

223300

Huai'An First People's Hospital, Huaian

225001

Northern Jiangsu People's Hospital, Yangzhou

225300

Jiangsu Taizhou People's Hospital, Taizhou

236000

First People's Hospital of Fuyang City, Fuyang

250013

Ji'nan Central Hospital, Jinan

266011

The Affiliated Hospital of Qingdao University, Qingdao

311200

The first people's Hospital of Xiaoshan District, Hangzhou

315010

Ningbo First Hospital, Ningbo

321100

Lanxi Municipal People's Hospital, Lanxi

322100

Dongyang People's Hospital, Jinhua

324000

Quzhou Hospital of Zhejiang University, Quzhou

325200

Ruian People's Hospital, Ruian

330006

The 2nd hospital of Nanchang university, Nanchang

361004

Xiamen Cardiovascular Hospital, Xiamen

400060

Chongqing Dianjiang People's Hospital, Chongqing

402160

Yongchuan hospital of chongqing medical university, Chongqing

404100

Chongqing Wanzhou People's Hospital, Chongqing

408000

Fuling center hospital of chongqing city, Chongqing

430060

Wuhan University - Renmin Hospital (Hubei General Hospital), Wuhan

450000

Henan Provincial People's Hospital, Zhengzhou

454001

Jiaozuo City Second People's Hospital, Jiaozuo

510580

The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou

528300

Shunde people's Hospital, Foshan

529000

Jiangmen Central Hospital, Jiangmen

Unknown

China Meitan General Hospital, Biejing

The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou

Zhuhai People's Hospital, Zhuhai

The Peoples Hspital of Hebi City, Hebi

Puyang Oilfield General Hosipital, Puyang

The first affiliated hospital of henan university of TCM, Zhengzhou

Zhengzhou No. 7 People's Hospital, Zhengzhou

The Affiliated Hospital of Medical College of Ningbo University, Ningbo

050000

The Second Hospital of Hebei University, Shijiazhuang

030024

Shanxi Cardiovascular Hospital, Taiyuan

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT02565615 - Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting | Biotech Hunter | Biotech Hunter